Back to search

Article

Efficient production of Moloney murine leukemia virus-like particles pseudotyped with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike protein

2020-09-16

Abstract excerpt

<h4>ABSTRACT</h4> The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak that started in China at the end of 2019 has rapidly spread to become pandemic. Several investigational vaccines that have already been tested in animals and humans were able to induce neutralizing antibodies against the SARS-CoV-2 spike (S) protein, however protection and long-term efficacy in humans remain to be demonstr...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ff7e9655-6a0a-579a-91b3-0138366b44ab
DOI
10.1101/2020.09.16.298992
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Efficient production of Moloney murine leukemia virus-like particles pseudotyped with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike proteinDOI 10.1101/2020.09.16.298992
Mammalian cells-based platforms for the generation of SARS-CoV-2 virus-like particlesSemantic proximity
A method for the generation of pseudotyped virus particles bearing SARS coronavirus spike protein in high yieldsSemantic proximity
Nanograms of SARS-CoV-2 Spike Protein Delivered by Exosomes Induce Potent Neutralization of Both Delta and Omicron VariantsSemantic proximity
Preclinical evaluation of manufacturable SARS-CoV-2 spike virus-like particles produced in Chinese Hamster Ovary cellsSemantic proximity
Immunogenicity of DNA vaccine encoding spike protein against Middle East respiratory syndrome coronavirus in mammalian modelSemantic proximity
Exosome based multivalent vaccine: achieving potent immunization, broadened reactivity, and strong T cell responses with nanograms of proteinsSemantic proximity
A broadly protective CHO cell expressed recombinant spike protein subunit vaccine (IMT-CVAX) against SARS-CoV-2Semantic proximity
Influenza Virus-like Particle (VLP) Vaccines Expressing the SARS-CoV-2 S Glycoprotein, S1, or S2 DomainsSemantic proximity
Nanograms of SARS-CoV-2 spike protein delivered by exosomes induce potent neutralization of both delta and omicron variantsSemantic proximity
Nanoparticle and virus-like particle vaccine approaches against SARS-CoV-2Semantic proximity
Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 SettingSemantic proximity
Rapid and Scalable Production of Functional SARS-CoV-2 Virus-like Particles (VLPs) by a Stable HEK293 Cell PoolSemantic proximity
Select a neighboring publication to make it the new centre.